Skip to main content

Find Clinical Trials

Home
Conditions
HER2-positive Refractory Advanced Cancer

Clinical trial condition

HER2-positive Refractory Advanced Cancer

Explore clinical trials studying HER2-positive Refractory Advanced Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

HER2-positive Refractory Advanced Cancer trial results

Completed

Safety and Clinical Activity of Lapatinib in Patients With HER2-positive Refractory Advanced Cancer

NCT02342587

Conditions: HER2-positive Refractory Advanced Cancer
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details